{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:56a47491-6377-45fa-9266-08b1c3814345","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T11:28:39.315499+00:00","published_at":"2026-10-17T04:46:59.013572+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1azmdu6chxbne","event_type":"GC_CHANGED","effective_at":"2026-04-09","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:charles-sermon","alpha:company:56a47491-6377-45fa-9266-08b1c3814345"],"caused_claim_ids":["alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:e0f2406ee1c33d106cc78d3c0a787662896c48cb7e3d150556784c9a36120102"],"summary":"Charles Sermon executive of Mereo BioPharma Group plc, effective 2026-04-09.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1vcbnbb1uke3h5","event_type":"CFO_CHANGED","effective_at":"2026-04-09","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:christine-fox","alpha:company:56a47491-6377-45fa-9266-08b1c3814345"],"caused_claim_ids":["alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:7556029759e89d4d4c3f5abc167d293f3f46bdffdf10642b8eb981b209f47536"],"summary":"Christine Fox executive of Mereo BioPharma Group plc, effective 2026-04-09.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:q6r3o2108i6mo","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:justin-roberts","alpha:company:56a47491-6377-45fa-9266-08b1c3814345"],"caused_claim_ids":["alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:23b12abce9dfcd93dd3ecc26a80a3795e690c7cc89f331f104d4652731de871b"],"summary":"Justin Roberts seat on Mereo BioPharma Group plc, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zrnfx31wvx0f","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:marc-yoskowitz","alpha:company:56a47491-6377-45fa-9266-08b1c3814345"],"caused_claim_ids":["alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:23b12abce9dfcd93dd3ecc26a80a3795e690c7cc89f331f104d4652731de871b"],"summary":"Marc Yoskowitz seat on Mereo BioPharma Group plc, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1pmckh4sef4yy","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:michael-s-wyzga","alpha:company:56a47491-6377-45fa-9266-08b1c3814345"],"caused_claim_ids":["alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:23b12abce9dfcd93dd3ecc26a80a3795e690c7cc89f331f104d4652731de871b"],"summary":"Michael S. Wyzga seat on Mereo BioPharma Group plc, effective 2019-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:5","subject_id":"alpha:company:56a47491-6377-45fa-9266-08b1c3814345","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:justin-roberts","object_label":"Justin Roberts","object_source_name_forms":[],"value":"Justin Roberts: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:justin-roberts","name":"Justin Roberts"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:23b12abce9dfcd93dd3ecc26a80a3795e690c7cc89f331f104d4652731de871b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Mereo BioPharma Group plc DEF 14A 2026-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","source_date":"2026-04-09","retrieved_at":"2026-04-24T23:46:00.544+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-09","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:6","subject_id":"alpha:company:56a47491-6377-45fa-9266-08b1c3814345","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:marc-yoskowitz","object_label":"Marc Yoskowitz","object_source_name_forms":[],"value":"Marc Yoskowitz: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:marc-yoskowitz","name":"Marc Yoskowitz"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:23b12abce9dfcd93dd3ecc26a80a3795e690c7cc89f331f104d4652731de871b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Mereo BioPharma Group plc DEF 14A 2026-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","source_date":"2026-04-09","retrieved_at":"2026-04-24T23:46:00.544+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-09","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:7","subject_id":"alpha:company:56a47491-6377-45fa-9266-08b1c3814345","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-s-wyzga","object_label":"Michael S. Wyzga","object_source_name_forms":[],"value":"Michael S. Wyzga: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-s-wyzga","name":"Michael S. Wyzga"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:23b12abce9dfcd93dd3ecc26a80a3795e690c7cc89f331f104d4652731de871b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Mereo BioPharma Group plc DEF 14A 2026-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","source_date":"2026-04-09","retrieved_at":"2026-04-24T23:46:00.544+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-09","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:8","subject_id":"alpha:company:56a47491-6377-45fa-9266-08b1c3814345","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:charles-sermon","object_label":"Charles Sermon","object_source_name_forms":[],"value":"Charles Sermon: General Counsel and Business Development","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:charles-sermon","name":"Charles Sermon"},"title":"General Counsel and Business Development","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-09","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:e0f2406ee1c33d106cc78d3c0a787662896c48cb7e3d150556784c9a36120102","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MREO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","source_date":"2026-04-09T00:00:00+00:00","retrieved_at":"2026-05-16T05:33:01.991545+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-09T00:00:00+00:00","effective_from":"2026-04-09","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:56a47491-6377-45fa-9266-08b1c3814345:leadership_role:9","subject_id":"alpha:company:56a47491-6377-45fa-9266-08b1c3814345","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christine-fox","object_label":"Christine Fox","object_source_name_forms":[],"value":"Christine Fox: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christine-fox","name":"Christine Fox"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-09","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:7556029759e89d4d4c3f5abc167d293f3f46bdffdf10642b8eb981b209f47536","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MREO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","source_date":"2026-04-09T00:00:00+00:00","retrieved_at":"2026-05-16T05:33:02.639511+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-09T00:00:00+00:00","effective_from":"2026-04-09","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:23b12abce9dfcd93dd3ecc26a80a3795e690c7cc89f331f104d4652731de871b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Mereo BioPharma Group plc DEF 14A 2026-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","source_date":"2026-04-09","retrieved_at":"2026-04-24T23:46:00.544+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e0f2406ee1c33d106cc78d3c0a787662896c48cb7e3d150556784c9a36120102","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MREO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","source_date":"2026-04-09T00:00:00+00:00","retrieved_at":"2026-05-16T05:33:01.991545+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7556029759e89d4d4c3f5abc167d293f3f46bdffdf10642b8eb981b209f47536","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MREO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","source_date":"2026-04-09T00:00:00+00:00","retrieved_at":"2026-05-16T05:33:02.639511+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.832,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.711,"cross_source_agreement":0.75,"temporal_completeness":1},"diagnostics":{"published_claims":9,"factual_claims":9,"claims_with_linked_evidence":9,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":5,"temporal_claims_with_valid_from":5,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:59.013572+00:00","observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":"2026-10-17T04:46:59.013572+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/mereo-biopharma-group-plc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/mereo-biopharma-group-plc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}